Link Pharma Chem Q4 FY26 Net Loss ₹40.86 Lakh

Link Pharma Chem reported audited FY26 results with a net profit of ₹7.69 lakh, a significant improvement from a ₹102.73 lakh loss in FY25.
The Board approved the re-appointment of Satish G. Thakur as Chairman and Rishikesh Thakur as Managing Director, both for 3-year terms subject to shareholder approval.
Q4 FY26 performance showed a net loss of ₹40.86 lakh despite revenue of ₹658.88 lakh, with full-year revenue reaching ₹2,743.15 lakh.
The company operates a single segment manufacturing chemicals and assessed no material financial impact from new Indian Labour Codes effective November 2025.